| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.034 | 0.5 |